secwatch / observer
8-K filed May 19, 2023, 7:59 PM ET ticker PETS CIK 0001040130
leadership confidence high sentiment neutral materiality 0.45

PetMed Express appoints Sandra Y. Campos as independent director; Jodi Watson to leave board

PETMED EXPRESS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sandra Y. Campos

Director
PETS · PETMED EXPRESS INC
Effective
2023-05-17
Filed
May 19, 2023, 7:59 PM ET
On May 17, 2023, the Board of Directors ("Board") of PetMed Express, Inc. (the "Company") approved the appointment of Sandra Y. Campos as a director on its Board
Departed

Jodi Watson

Director
PETS · PETMED EXPRESS INC
Effective
2023-08-03
Filed
May 19, 2023, 7:59 PM ET
On May 16, 2023, Jodi Watson informed the Board that she does not wish to stand for re-election to the Board when her term expires at the Company's 2023 Annual Meeting of Shareholders on August 3, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandra Y. Campos was appointed as Director at PETMED EXPRESS INC.

Action
appointed
Role
Director
Exact text from the filing
On May 17, 2023, the Board of Directors ("Board") of PetMed Express, Inc. (the "Company") approved the appointment of Sandra Y. Campos as a director on its Board
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jodi Watson departed as Director at PETMED EXPRESS INC.

Action
not stand for re-election
Role
Director
Exact text from the filing
On May 16, 2023, Jodi Watson informed the Board that she does not wish to stand for re-election to the Board when her term expires at the Company's 2023 Annual Meeting of Shareholders on August 3, 2023
View on SEC.gov

PETMED EXPRESS INC filing history →

Source: SEC EDGAR
accession 0001040130-23-000023
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.